Direct fill therapy

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Oper. in, Oper. out

Operations: NOMESCO codes SFA

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector OPER_SFA

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 2159 1139 1020
Unadjusted prevalence (%) 0.83 0.78 0.90
Mean age at first event (years) 49.74 47.86 51.83

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.08 5.84 [2.65, 12.85] 1.2e-5 195
15 years 0.04 5.90 [2.79, 12.52] 3.6e-6 187
5 years 0.01 13.43 [8.38, 21.52] 3.4e-27 135
1 year - - - -

Correlations

Index endpoint: OPER_SFA – Direct fill therapy
GWS hits:

Survival analyses between endpoints

Plot

before Direct fill therapy
after Direct fill therapy

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Direct fill therapy